Literature DB >> 23924004

Glucose levels and risk of dementia.

Paul K Crane1, Rod Walker, Rebecca A Hubbard, Ge Li, David M Nathan, Hui Zheng, Sebastien Haneuse, Suzanne Craft, Thomas J Montine, Steven E Kahn, Wayne McCormick, Susan M McCurry, James D Bowen, Eric B Larson.   

Abstract

BACKGROUND: Diabetes is a risk factor for dementia. It is unknown whether higher glucose levels increase the risk of dementia in people without diabetes.
METHODS: We used 35,264 clinical measurements of glucose levels and 10,208 measurements of glycated hemoglobin levels from 2067 participants without dementia to examine the relationship between glucose levels and the risk of dementia. Participants were from the Adult Changes in Thought study and included 839 men and 1228 women whose mean age at baseline was 76 years; 232 participants had diabetes, and 1835 did not. We fit Cox regression models, stratified according to diabetes status and adjusted for age, sex, study cohort, educational level, level of exercise, blood pressure, and status with respect to coronary and cerebrovascular diseases, atrial fibrillation, smoking, and treatment for hypertension.
RESULTS: During a median follow-up of 6.8 years, dementia developed in 524 participants (74 with diabetes and 450 without). Among participants without diabetes, higher average glucose levels within the preceding 5 years were related to an increased risk of dementia (P=0.01); with a glucose level of 115 mg per deciliter (6.4 mmol per liter) as compared with 100 mg per deciliter (5.5 mmol per liter), the adjusted hazard ratio for dementia was 1.18 (95% confidence interval [CI], 1.04 to 1.33). Among participants with diabetes, higher average glucose levels were also related to an increased risk of dementia (P=0.002); with a glucose level of 190 mg per deciliter (10.5 mmol per liter) as compared with 160 mg per deciliter (8.9 mmol per liter), the adjusted hazard ratio was 1.40 (95% CI, 1.12 to 1.76).
CONCLUSIONS: Our results suggest that higher glucose levels may be a risk factor for dementia, even among persons without diabetes. (Funded by the National Institutes of Health.)

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23924004      PMCID: PMC3955123          DOI: 10.1056/NEJMoa1215740

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  26 in total

Review 1.  Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation.

Authors:  Sónia C Correia; Renato X Santos; Cristina Carvalho; Susana Cardoso; Emanuel Candeias; Maria S Santos; Catarina R Oliveira; Paula I Moreira
Journal:  Brain Res       Date:  2012-01-12       Impact factor: 3.252

2.  Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older.

Authors:  Eric B Larson; Li Wang; James D Bowen; Wayne C McCormick; Linda Teri; Paul Crane; Walter Kukull
Journal:  Ann Intern Med       Date:  2006-01-17       Impact factor: 25.391

3.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

Review 4.  The worldwide diabetes epidemic.

Authors:  David W Lam; Derek LeRoith
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-04       Impact factor: 3.243

5.  Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women.

Authors:  K Yaffe; T Blackwell; R A Whitmer; K Krueger; E Barrett Connor
Journal:  J Nutr Health Aging       Date:  2006 Jul-Aug       Impact factor: 4.075

6.  Insulin has multiple antiamyloidogenic effects on human neuronal cells.

Authors:  Giuseppe Pandini; Vincenza Pace; Agata Copani; Sebastiano Squatrito; Danilo Milardi; Riccardo Vigneri
Journal:  Endocrinology       Date:  2012-12-13       Impact factor: 4.736

7.  Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways.

Authors:  Jasmin Bartl; Andrea Meyer; Svenja Brendler; Peter Riederer; Edna Grünblatt
Journal:  J Neural Transm (Vienna)       Date:  2012-07-11       Impact factor: 3.575

Review 8.  Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.

Authors:  Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

Review 9.  Epidemiology of Alzheimer disease.

Authors:  Christiane Reitz; Carol Brayne; Richard Mayeux
Journal:  Nat Rev Neurol       Date:  2011-02-08       Impact factor: 42.937

10.  Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects.

Authors:  C Enzinger; F Fazekas; P M Matthews; S Ropele; H Schmidt; S Smith; R Schmidt
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

View more
  231 in total

1.  Higher Fasting Plasma Glucose Levels, within the Normal Range, are Associated with Decreased Processing Speed in High Functioning Young Elderly.

Authors:  Meytal Raizes; Odelia Elkana; Motty Franko; Ramit Ravona Springer; Shlomo Segev; Michal Schnaider Beeri
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

2.  Glucevia Fraxinus excelsior Extract Effectively Controls Blood Glucose Levels in Randomized, Controlled Trial.

Authors:  Thomas Ughetto
Journal:  Integr Med (Encinitas)       Date:  2014-08

3.  Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.

Authors:  Katherine J Bangen; Jayandra J Himali; Alexa S Beiser; Daniel A Nation; David J Libon; Caroline S Fox; Sudha Seshadri; Philip A Wolf; Ann C McKee; Rhoda Au; Lisa Delano-Wood
Journal:  J Alzheimers Dis       Date:  2016-07-06       Impact factor: 4.472

Review 4.  [Diabetes and the central nervous system].

Authors:  F Erbguth
Journal:  Nervenarzt       Date:  2017-06       Impact factor: 1.214

5.  Amyloid precursor protein in pancreatic islets.

Authors:  Joshua A Kulas; Kendra L Puig; Colin K Combs
Journal:  J Endocrinol       Date:  2017-07-14       Impact factor: 4.286

Review 6.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

7.  Bridging the Translation Gap: From Dementia Risk Assessment to Advice on Risk Reduction.

Authors:  Kaarin J Anstey; Ranmalee Eramudugolla; Diane E Hosking; Nicola T Lautenschlager; Roger A Dixon
Journal:  J Prev Alzheimers Dis       Date:  2015

8.  High-Normal Adolescent Fasting Plasma Glucose Is Associated With Poorer Midlife Brain Health: Bogalusa Heart Study.

Authors:  Owen Carmichael; Patrick Stuchlik; Sreekrishna Pillai; Geert-Jan Biessels; Ram Dhullipudi; Anna Madden-Rusnak; Shane Martin; Daniel S Hsia; Vivian Fonseca; Lydia Bazzano
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

Review 9.  Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art.

Authors:  Suzanne M de la Monte
Journal:  Expert Opin Drug Deliv       Date:  2013-11-12       Impact factor: 6.648

10.  Vascular complications of diabetes: natural history and corresponding risks of dementia in a national cohort of adults with diabetes.

Authors:  Po-Yin Chang; I-T Ing Wang; Chern-En Chiang; Chen-Huan Chen; Wan-Yu Yeh; Victor W Henderson; Yi-Wen Tsai; Hao-Min Cheng
Journal:  Acta Diabetol       Date:  2021-02-23       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.